Friday, 10 Apr 2020

Autoimmune/Lupus

Datesort ascending Type Title Save
11 Feb 2020 Social Large UK database looked at 1281 Behcet Dz pts - prevalence of BD was 14.61 per 100k. BD was at increased risk of ischaemic heart disease [aHR 3.09), venous thrombosis [aHR 4.80] and mortality [aHR 1.40] iVS 5K controls. https://t.co/FghxE6bAZ0
11 Feb 2020 Blog ACR20 Pearls Part 3: Pragmatic Applications for Managing Vasculitis
03 Feb 2020 Social Study of 368 SLE pts (1998 to 2012) found a high prevalence of epilepsy. Survey suggested epilepsy in 42% but evaluation found 36 (11.5%) w/ Sx, 83% w/ focal onset. Other manifestations of NPSLE in 50%, w/ 2-3 fold higher risk of CVA, psychosis & APS
03 Feb 2020 News EULAR Recommendations on Sjögren’s Syndrome
30 Jan 2020 ACR Video QD Clinic - Vasculitis Monitoring
30 Jan 2020 Social CDC reports 4 case cluster of Lyme disease at a N. Carolina wilderness camp, 3 in children aged 6–8 yrs. All were positive B. burgdorferi IgM western blot. NC has a low incidence of reported Lyme disease cases
28 Jan 2020 Social Prospectively study of neuropsychiatric (NP) events in1827 SLE - found that NP-SLE occured in 52%; with 31% directly attributed to SLE. Risk of NP-SLE was highest in the first 2 years (RR 6.16) and mortality risk was higher in NP-SLE pts ((16% vs 7%) https://t.co/03wfX5SxNm
27 Jan 2020 Social Administrative claims study from British Columbia showed the risk of type 2 diabetes is significantly lower in SLE pts taking Plaquenil (HCQ). 1,498 SLE pts (91% F) were followed 4.6 yrs with 140 incident T2DM; lower HR (0.61) for those adherent to HCQ https://t.co/OqUQtHz6Hf
20 Jan 2020 News Steroid-Sparing Effect of Tocilizumab in Refractory Takayasu Arteritis
16 Jan 2020 News TULIP2 - Anifrolumab Succeeds in Lupus
13 Jan 2020 News Steroids Up the Risk of Organ Damage in SLE
10 Jan 2020 Social Among 1827 SLE pts, 52.3% had neuropsychiatric (NP) events attributed to SLE. In first 2 years the relative risk for SLE NP events was 6.16. Mortality was higher with NP events attributed to SLE (16%) versus no NPSLE events (6%) https://t.co/uCx5Uf9kJj
10 Jan 2020 News Treatment of Statin-induced anti-HMGCR myopathy
09 Jan 2020 Social Dr. Heidi Jacobi #UTSW lecturing on scleromyxedema often with "pebble like" lesions that during it from scleroderma https://t.co/5odVXrglyT
03 Jan 2020 Social Check out my 2019 Rheumatology Year in Review - now on RheumNow https://t.co/sYb3KvivJK
28 Dec 2019 Social Kaiser Permanente study of 1,956 adult #SLE patients shows that only 58% of lupus pts were ≥80% adherent to hydroxychloroquine. Only age and increasing visits were predictive. Not predictive were the rheumatologist, center or socioeconomic factors. https://t.co/m0oN1OC9bn
27 Dec 2019 Social Antiphospholipid syndrome incidence is 5 per 100k/Yr; lesser known complications include Libman Sachs valve dz, livedo reticularis, racemosa, skin ulcers/necrosis, GN, thrombotic microangiopathy, AVN, non-traumatic fractures https://t.co/rWlWZ39Lhd
27 Dec 2019 Social Check out last weeks RheumNow Podcast - A Merry Lupus XMAS! videocast >> https://t.co/rFJQjVJIOc or the podcast >> https://t.co/blaXn1N5By
24 Dec 2019 News Best of 2019 - 2019 EULAR Guidelines on Antiphospholipid Syndrome Management
24 Dec 2019 News Best of 2019 - New EULAR/ACR Classification Criteria for SLE